CORBUS PHARMACEUTICALS HOLDI (CRBP)

US21833P3010 - Common Stock

13  -0.33 (-2.48%)

After market: 13 0 (0%)

Buy % Consensus

86

ChartMill assigns a Buy % Consensus number of 86% to CRBP. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 57.91. This target is 345.49% above the current price.
CRBP was analyzed by 14 analysts. The buy percentage consensus is at 86. So analysts seem to be very confident about CRBP.
In the previous month the buy percentage consensus was at a similar level.
CRBP was analyzed by 14 analysts, which is quite many. So the average rating should be quite meaningful.

Price Target & Forecast

Price Low Median Mean High 13.0035.3561.2057.9178.75 - 171.92% 370.77% 345.49% 505.77%
Up and Down Grades
Date Firm Action Rating
2024-12-02 Piper Sandler Initiate Overweight
2024-09-23 HC Wainwright & Co. Reiterate Buy -> Buy
2024-09-20 Mizuho Reiterate Outperform -> Outperform
2024-09-20 RBC Capital Reiterate Outperform -> Outperform
2024-09-20 B. Riley Securities Maintains Buy -> Buy
2024-09-20 Wedbush Maintains Outperform -> Outperform
2024-08-28 RBC Capital Reiterate Outperform -> Outperform
2024-08-07 Oppenheimer Maintains Outperform -> Outperform
2024-08-07 RBC Capital Reiterate Outperform -> Outperform
2024-08-06 HC Wainwright & Co. Reiterate Buy -> Buy
2024-07-22 HC Wainwright & Co. Reiterate Buy
2024-07-10 Oppenheimer Reiterate Outperform -> Outperform
2024-06-26 B. Riley Securities Initiate Buy
2024-06-11 RBC Capital Maintains Outperform -> Outperform
2024-06-03 Oppenheimer Maintains Outperform -> Outperform
2024-05-13 RBC Capital Initiate Outperform
2024-05-08 Oppenheimer Maintains Outperform -> Outperform
2024-03-13 Oppenheimer Reiterate Outperform -> Outperform
2024-03-06 Jefferies Upgrade Hold -> Buy
2024-01-29 Oppenheimer Maintains Outperform -> Outperform
2023-08-09 Oppenheimer Reiterate Outperform -> Outperform
2023-05-10 Oppenheimer Upgrade Perform -> Outperform
2023-03-08 HC Wainwright & Co. Reiterate Buy
2023-02-14 HC Wainwright & Co. Reiterate Buy